Susquehanna International Group’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Susquehanna International Group’s Portfolio PARN Stock Details PARN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-36,817	Closed	-$25K	–	10961
2016 Q4	$25K	Buy	+36,817	New	+$43.9K	﹤0.01%	9409

Other funds holding PARN

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Susquehanna International Group's PARN Position: Q1 2017 in Review

Susquehanna International Group sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 36,817 shares — an estimated $25K sold.

Susquehanna International Group first reported a position in PARN in Q4 2016 and held it in 1 quarter. The position peaked at $25K in Q4 2016. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

Susquehanna International Group reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
Susquehanna International Group sold 36,817 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017, an estimated $25K.
Susquehanna International Group first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q4 2016 and held it in 1 quarter.
Susquehanna International Group's Parnell Pharmaceuticals Holdings Ltd position peaked at $25K in Q4 2016.
2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.